Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Boehringer Ingelheim
Cantor Fitzgerald
US Department of Justice
Express Scripts

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076582

« Back to Dashboard

NDA 076582 describes FENOLDOPAM MESYLATE, which is a drug marketed by Luitpold, Sandoz Inc, Teva Parenteral, and West-ward Pharms Int, and is included in four NDAs. Additional details are available on the FENOLDOPAM MESYLATE profile page.

The generic ingredient in FENOLDOPAM MESYLATE is fenoldopam mesylate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fenoldopam mesylate profile page.
Summary for 076582
Applicant:West-ward Pharms Int
Ingredient:fenoldopam mesylate
Medical Subject Heading (MeSH) Categories for 076582

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Oct 12, 2004TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.